Recent analysis of the genetic sequence of the coronavirus has indicated that the infection may have spread further than we realised.
Genomics will change what patients expect from their provider, as well as change how physicians treat them. Before this happens, education on both sides is needed. This month we look at some of the big talking points.
Researchers hope that the effort will be able to validate liquid biopsy (LB) diagnostic methods for childhood lymphomas that are endemic in the region
John Hopkins University has announced a partnership with Cambridge-based start-up, Capsulomics, to study the detection of oesophageal cancer and Barrett’s oesophagus.
Late on Friday, the FDA authorised the marketing of the first genetic test for Fragile X syndrome (FXS): AmplideX, a Fragile X diagnostic and carrier screen kit from Asuragen. The press release can be found here.
York Governor, Andrew Cuomo, announced legislation to launch a consortium of public and private research groups to investigate the genetics of Alzheimer’s disease. The five-year initiative, called the SUNY Curing Alzheimer’s Health Consortium, will analyse the genetics of 1 million people who suffer from or are at risk of developing Alzheimer’s disease over 5 years.
Even on Valentine’s Day the snoring of a sleeping companion, can be a hard habit to excuse. And, while a UK Biobank analysis may not help to silence-the-snooze of your significant other, the insights published today are interesting, nonetheless. The observational and genetic study of 400,000 snoring and non-snoring participants using data from the UK […]
Interview with Dr Halima Moncrieffe, Assistant Professor, Cincinnati Children’s Hospital Medical Center
Dr Halima Moncrieffe is an Assistant Professor at Cincinnati Children’s Hospital, ranked top 3 in the USA, where she combines genomics with immunology to understand medication response and disease etiology. Halima is an award-winning immunologist who’s ultimate goal is to move towards a cure for Juvenile Idiopathic Arthritis, so children can live pain-free and to their full potential
Dr Michelle Krishnan is the Translational Medicine Leading in Rare Diseases at Roche where she focuses on developing transformative therapies for rare neurodevelopmental disorders to deliver meaningful benefit for patients and families, and is responsible for the clinical development of programmes from early research to clinical trials.
Karen Lighting Jones, Head of Future Place at Roche. Back in 2016, Dame Sally Davies concluded her Chief Medical Officer annual report by saying “Genomics is not tomorrow, it’s here today. I believe genomic services should be available to more patients, whilst being a cost-effective service in the NHS”.
Interview with Dr Susie Cooke, Head of Medical Genomics at the Glasgow Precision Oncology Laboratory
Dr Susie Cooke is the Head of Medical Genomics at the Glasgow Precision Oncology Laboratory whose main interest is in facilitating the move of next-generation sequencing into the clinic to help cancer patients.
Get past the hype and bias in sequencing vendor marketing materials, and get an unbiased, highly informed view from a highly qualified professional whose job it is to evaluate sequencing technologies for a world leading healthcare and research institution – the Mayo Clinic. Get a base- to high-level understanding of the sequencing process, to give […]
Scientists at Navega Therapeutics in San Diego, California have discovered a way to target DNA to stop pain signals being sent and eliminate pain. In an article published by Pharmafile, the treatment could be available in five years to help sufferers of chronic pain or with long-term pain problems.
Illumina, Inc. (Illumina) and Pacific Biosciences of California, Inc. (PacBio) announced that they have mutually agreed to terminate their merger agreement. The merger was first proposed in November 2018 that Illumina would be acquiring PacBio at a fully diluted enterprise value of ~$1.2 billion. Now with the merger terminated, Illumina will have to pay a termination fee of $98 million to PacBio.
Researchers at Penn Medicine have developed an imaging technique that can provide a non-invasive characterisation of tumour heterogeneity. They used Magnetic Resonance Imaging (MRI) and radiomics – an emerging field of medicine that uses algorithms to extract large amounts of features from medical images
Scientists have developed a new genetic risk score that is similarly or more predictive than commonly known risk factors for stroke. They developed this meta-scoring approach model to identify individuals at a 3-fold increased risk of developing ischaemic stroke – one of the leading causes of disability and death world-wide